Issue №5-99, 2020

Review article

https://doi.org/10.38025/2078-1962-2020-99-5-101-106

Analysis of the Existing Treatment Methods of Musculoskeletal Disorders in Adult Patients with Mucopolysaccharidosis (Literature Review)

View article (Download PDF file)



Download XML file

1 ORCIDEremushkin M.A., 1 ORCIDOtvetchikova D.I., 2 ORCIDOtvetchikov I.N., 1 ORCIDKolyshenkov V.A.

1 National Medical Research Сenter of Rehabilitation and Balneology, Moscow, Russian Federation
2 Clinical hospital №17, Moscow, Russian Federation


ABSTRACT

Need for optimal treatment approaches for adult patients with mucopolysaccharidosis is an urgent problem today. This happened due to the fact that previously patients with MS rarely lived to adulthood and were observed mainly by pediatricians. But with the evolution of medical technologies and the emergence of modern methods of treatment and rehabilitation of such patients, the number of adult patients with MS is increasing. Clinicians have more and more questions in choosing a strategy for managing each specific clinical case. Currently, a comprehensive approach to treatment allows for the use of a multidisciplinary team to pay due attention to concomitant diseases that occur in patients with impaired GAG metabolism. Due to the rarity of this disease in the modern literature, there are a small number of publications that cover only certain aspects of the disease, but there are no works devoted to a comprehensive approach to the treatment and rehabilitation of such patients. The analysis of literature data on diagnostics, methods of examination, options for conservative and surgical treatment depending on the type of detected pathology and functional needs of a patient with different types of MS is carried out. Recommendations for testing and evaluating functional status are described, and the most common options for conservative and surgical treatment that take into account specific problems that reduce the patient’s quality of life are presented. It is necessary to study the problem of MPs in adult patients in more detail, as well as to coordinate specialists who have experience in managing patients with metabolic disorders, in order to improve the results of treatment and rehabilitation of patients with this pathology.


KEYWORDS: mucopolysaccharidosis, orphan diseases, metabolic disorders, glycosaminoglycans, connective tissue dysplasia, systemic diseases

For citation: Eremushkin M.A., Otvetchikova D.I., Otvetchikov I.N., Kolyshenkov V.A. Analysis of the Existing treatment Methods of Musculoskeletal Disorders in Adult Patients with Mucopolysaccharidosis (Literature Review). Bulletin of Rehabilitation Medicine. 2020; 5 (99): 101-106. https://doi.org/10.38025/ 2078-1962-2020-99-5-101-106



References:

  1. Taylor N.E., Dengel D.R., Lund T.C. Polgreen Journal of Pediatric Rehabilitation Medicine: An Interdisciplinary Approach. 2014; (7): 353-360.
  2. Mitchell J., Berger K.I., Borgo A., Braunlin E.A., Burton B.K., Ghotme K.A., Kircher S.G., Molter D., Orchard P.J., Palmer J., Pastores G.M., Rapoport D.M., Wang R.Y., White K. Unique medical issues in adult patients with mucopolysaccharidoses. European Journal of Internal Medicine. 2016; (34): 2-10. DOI:10.1016/j. ejim.2016.05.017
  3. Wraith J.E., Beck M., Giugliani R., Wraith J.E., Beck M., Giugliani R., Clarke J., Martin R., Muenzer J. On behalf of the HOS Investigators. Initial report from the Hunter Outcome Survey. Genetics in Medicine. 2008; (10): 508-516. DOI:10.1097/gim.0b013e31817701e6
  4. Harmatz P., Mengel K.E., Giugliani R., Valayannopoulos V., Lin S., Parini R., Guffon N., Burton B.K., Hendriksz C.J., Mitchell J., Martins A., Jones S., Guelbert N., Vellodi A., Hollak C., Slasor P., Decker C. The Morquio A Clinical Assessment Program: baseline results illustrating progressive, multisystemic clinical impairments in Morquio A subjects. Molecular Genetics and Metabolism. 2013; (109): 54-61.
  5. White K.K., Harmatz P. Orthopedic management of mucopolysaccharide disease. Journal of pediatric rehabilitation medicine. 2010; (3): 47-56. DOI:10.3233/PRM-2010-0102
  6. Hendriksz C.J., Giugliani R., Harmatz P. Recommendations for the management of MPS IVA: systematic evidence- and consensus-based guidance. Clinical Surveillance Program (CSP). 2011; (36): 373-384. DOI:10.1186/s13023-019-1074-9
  7. White K.K., Karol L.A., White D.R., Hale S. Musculoskeletal manifestations of Sanfilippo Syndrome (mucopolysaccharidosis type III). Journal of Pediatric Orthopaedic. 2011; (31): 594-608. DOI:10.1097/BPO.0b013e31821f5ee9
  8. Borovikova O.I. Tipy mukopolisaharidozov i klinicheskie proyavleniya. [Types of mucopolysaccharidosis and clinical manifestations]. Schastlivaya beremennost’. 2019: 47-51 (In Russ.).
  9. Lachman R., Martin K.W., Castro S., Basto M.A., Adams A., Teles E.L. Radiologic and neuroradiologic findings in the mucopolysaccharidoses. Journal of pediatric rehabilitation medicine. 2010; (3): 109-118. DOI:10.3233/PRM-2010-0115
  10. Aldenhoven M., Wynn R.F., Orchard P.J., O’Meara A., Veys P., Fischer A., Valayannopoulos V., Neven B., Rovelli A., Prasad V.K., Tolar J., Allewelt H., Jones S., Parini R., Renard M., Bordon V., Wulffraat N.M., Koning T.J., Shapiro E.G., Kurtzberg J., Boelens J.J. Long-term outcome of Hurler syndrome patients after hematopoietic cell transplantation: an international multicenter study. Blood. 2015; (125): 2164-2172. DOI:10.1182/blood-2014-11-608075
  11. Giugliani R., Herber S., Camargo de, Pinto L.L, Baldo G. Therapy for mucopolysaccharidosis VI: (Maroteaux-Lamy syndrome) present status and prospects. Pediatric Endocrinology Reviews. 2014; 12 (1): 152-158.
  12. Hendriksz C.J., Lavery C., Coker M., Ucar S.K., Jain M., Bell L., Lampe C. Burden of disease in patients with Morquio A syndrome: results from an international patient-reported outcomes survey. Orphanet Journal of Rare Diseases. 2014; (9): 32 p. DOI:10.1186/1750-1172-9-32
  13. White K.K., Jester A., Bache C.E., Harmatz P.R., Shediac R., Thacker M.M., Mackenzie W.G. Orthopedic management of the extremities in patients with Morquio A syndrome. Journal of Children’s Orthopaedics. 2014; (8): 295-304.
  14. Scarpa M., Almassy Z., Beck M., Scarpa M., Almassy Z., Beck M., Bodamer O., Bruce I.A., De Meirleir L., Guffon N., Guillen-Navarro E., Hensman P., Jones S., Kamin W., Kampmann C., Lampe C., Lavery C.A., Teles E.L., Link B., Lund A.M., Malm G., Pitz S., Rothera M., Stewart C., Tylki-Szymanska A., van der Ploeg A., Walker R., Zeman J., Wraith J.E. Hunter Syndrome Europena Expert Council. Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease. Orphanet Journal of Rare Diseases. 2011; (6): 72 p.
  15. Hendriksz C.J., Berger K.I., Giugliani R., Harmatz P., Kampmann C., Mackenzie W.G., Raiman J., Villarreal M.S., Savarirayan R. International guidelines for the management and treatment of Morquio A syndrome. American Journal of Medical Genetics part A. 2015; (167A): 11-25.
  16. Thawrani D.P., Walker K., Polgreen L.E., Tolar J., Orchard P.J. Hip dysplasia in patients with Hurler syndrome (mucopolysaccharidosis type 1H). Journal of Pediatric Orthopaedics. 2013; (33): 635-643. DOI:10.1097/BPO.0b013e31829abfe0
  17. O’heireamhoin S., Bayer T., Mulhall K.J. Total hip arthroplasty in mucopolysaccharidosis type IH. Case Reports in Orthopedics. 2011; (2011): 832439.
  18. Montano A.M., Tomatsu S., Brusius A., Smith M., Orii T. Growth charts for patients affected with Morquio A disease. American Journal of Medical Genetics part A. 2008; (146A): 1286-1295. DOI:10.1002/ajmg.a.32281
  19. Cimaz R., La Torre F. Mucopolysaccharidoses. Current Rheumatology Reports. 2014; (16): 389 p. DOI:10.1007/s11926-013-0389-0
  20. Prohorova E.S., Urazgil’deev R.Z., Eremushkin M.A., Kolyshenkov V.A. Sovremennye podhody k lecheniyu pacientov s lozhnymi sustavami i defektami dlinnyh kostej nizhnih konechnostej: analiticheskij obzor. [Modern treatment approaches in patients with false joints and lower extremities long bones defects: analytical review]. Bulletin of Rehabilitation Medicine. 2020; (2): 84-89. DOI:10.38025/2078-1962-2020-96-2-84-89 (In Russ.).
  21. Lotters F., van Tol B., Kwakkel G., Gosselink R. Effects of controlled inspiratory muscle training in patients with COPD: a meta analysis. European Respiratory Journal. 2002; (20): 570-576. DOI:10.1183/09031936.02.00237402
  22. Savci S., Ozturk M., Inal-Ince D., Gultekin Z., Arikan H.,Sivri H.S. Inspiratory muscle training in Morquio’s syndrome: A case study. Pediatric Pulmonology. 2006; 41(12): 1250-1253. DOI:10.1002/ppul.20500
  23. Larson J.L., Covey M.K, Wirtz S.E., Berry J.K., Alex C.G., Langbein W.E., Edwards L. Cycle ergometer and inspiratory muscle training in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine. 1999; (160): 500-507. DOI:10.1164/ajrccm.160.2.9804067
  24. Eremushkin M.A. Readaptaciya sredstvami funkcional’noj terapii detej s osteohondroplaziyami, soprovozhdayushchimisya nanizmom i subnanizmom. Kand, Diss. [Re-adaptation by means of functional therapy of children with osteochondroplasia, accompanied by nanism and subnanism. Cand. Diss.]. FGBU “NMIC TO im. N.N. Priorova” MZ RF. Moscow. 1999: 159 p. (In Russ.).
  25. Mihajlova L.K., Kuleshov A.A., Arzhakova N.I., Sokolova T.V., Vetrile M.S., Shvachka I.V., Polyakova O.A., Gromov I.S. Sindrom Maroto-Lami -mukopolisaharidoz VI tipa: sluchaj iz praktiki (oshibki i oslozhneniya). [Maroto-Lamy syndrome - mucopolysaccharidosis type VI: a case from practice (errors and complications)]. Genij ortopedii. 2017; 23(1): 80-84 (In Russ.).
  26. Pereverzev V.S. Patologiya pozvonochnika u pacientov s mukopolisaharidozom (MPS) razlichnyh tipov: osobennosti diagnostiki i hirurgicheskogo lecheniya. Kand, Diss. [Spinal pathology in patients with mucopolysaccharidosis (MPS) of various types: features of diagnosis and surgical treatment: Cand. Diss.].”NMIC TO im. N.N. Priorova” MZ RF. Moscow. 2019: 176 p. (In Russ.).
  27. Vashakmadze N.D. Mul’tidisciplinarnye principy vedeniya detej s mukopolisaharidozom v povyshenii effektivnosti ih diagnostiki i lecheniya. Dokt, Diss. [Multidisciplinary principles of management of children with mucopolysaccharidosis in improving the efficiency of their diagnosis and treatment: Doct. Diss.]. FGAU “NMIC zdorov’ya detej” MZ RF. Moscow. 2019: 306 p. (In Russ.).



Creative Commons License
The content is available under the Creative Commons Attribution 4.0 License.

©

Эта статья открытого доступа по лицензии CC BY 4.0. Издательство: ФГБУ «НМИЦ РК» Минздрава России.
This is an open article under the CC BY 4.0 license. Published by the National Medical Research Center for Rehabilitation and Balneology.